Identifier |
walsh_2019_s1_c5 |
Title |
Go With Your Gut Feeling |
Creator |
Paul Freund; Ari Shemesh; Gabriella Mankovskii; Ana Pejovic-Milic; David Howarth; Edward Margolin |
Affiliation |
(PF) (AS) (DH) (EM) University of Toronto, Toronto, ON, Canada; (GM) (AP) Ryerson University, Toronto, Canada |
Subject |
Optic Neuropathy; Afferent Visual Pathways; Nutritional; Toxic |
Description |
Serum heavy metal screening was performed. Unexpectedly, the level of arsenic was 5x upper limit of normal. This was confirmed on repeated testing 1 month later. Patient's partner was tested with normal results. Detailed questioning for possible sources of environmental, occupational, or recreational exposures that would put patient at risk of arsenic exposure were all unrevealing. Since serum arsenic is cleared within 24-48 hours of exposure, there was continuing exposure to arsenic. When asked whether he has any hobbies, patient thought and responded that he goes to his remote cottage weekly. When partner's normal testing was brought up, the patient said that he always goes to his cabin alone. When asked about the water source at the cottage, patient immediately recalled the water was well-sourced and not municipal. Reviewing his medical history, remote history of hemorrhagic colitis requiring colectomy was consistent with acute arsenic poisoning. When deed of purchase for the cottage was located, it was identified that hemorrhagic colitis occurred 3 months after the cottage was was bought 28 years ago. Pathology slides from the colectomy were retrieved and re-examined by several gastrointestinal pathologists who agreed that the samples were not consistent with previous diagnosis of Crohn's colitis. A research laboratory with the capability to perform Total Reflection X-ray Fluorescence (TXRF) was contacted and a sample of the colonic tissue excised 28 years ago was analyzed. Arsenic content of the colon was measured and was found to be 5.9 ppb, 3 to 10 times the mean arsenic concentrations found in visceral organs of normal subjects. Well water from the cottage is currently being tested. In retrospect, persistent mild leukopenia and thrombocytopenia were also consistent with arsenic toxicity. Thus, in this case, chronic exposure to arsenic for 28 years caused slowly progressive toxic optic neuropathy. |
History |
71 year-old man noticed a "smudge" in his central vision when reading that was gradually progressing over a year. Medical history was significant for one episode of hemorrhagic colitis requiring colectomy 28 years ago diagnosed as Crohn's disease, atrial fibrillation, and congenital dyschromatopsia. He worked as psychiatrist, did not drink alcohol, and quit smoking many years ago. Vision was 20/80 in the right eye and 20/60 in the left. Formal visual fields were full with bilateral decrease in foveal sensitivity. Foveal granularity was noted and retinal referral was made, however, no evidence of maculopathy was seen by retinologist. One year later, vision changed to 20/50 and 20/300. There was now questionable bilateral optic nerve pallor. CBC, ESR, CRP, ACE, ANA, VDRL, Vitamin B12 and folate were all normal except for mild leukopenia and thrombocytopenia. MRI brain/orbits without contrast was performed and was normal. Testing for LHON was negative. Multifocal ERG showed decreased cone responses. Patient was re-evalauted by the retinal service, but no diagnosis was made. Vision continued to deteriorate to 20/200 and CF a year later. Investigations for neuromyelitis optica (NMO antibody testing with ELISA technique and contrast-enhanced MRI brain/spine) were negative. OCT of the RNFL was normal with no thinning of the papillomacular bundle. Patient was lost to follow-up for 4 years before returning to clinic 7 years after initial presentation, now with 20/400 and CF visual acuities. Visual fields demonstrated larger central scotomas in each eye. RNFL OCT remained unchanged, however, OCT of the macular ganglion cell complex demonstrated severe bilateral thinning. The following tests were performed: CBC, ESR, CRP, ANA, VDRL, ACE, Vitamin B12, Folate, NMO antibodies (cell-based assay technique), anti-MOG antibodies, and MRI brain/orbits/spine with contrast. All testing was negative again except for mild leukopenia and thrombocytopenia. A diagnostic procedure was performed. |
Disease/Diagnosis |
Bilateral symmetric optic neuropathy secondary to chronic arsenic toxicity. |
Date |
2019-03 |
References |
Dang, Jaiswal, Somasundaram. Distribution of Arsenic in Human Tissues and Milk. The Science of the Total Environment, 29, pp 171-175, 1983. Graeme, Pollock. Heavy Metal Toxicity, Part I: Arsenic and Mercury. The Journal of Emergency Medicine, 16(1), pp 45-56, 1998. Vahidnia, van der Voet, de Wolff. Arsenic neurotoxicity - A review. Human & Experimental Toxicology, 26, pp 823-832, 2007. |
Language |
eng |
Format |
video/mp4 |
Type |
Image/MovingImage |
Source |
2019 North American Neuro-Ophthalmology Society Annual Meeting |
Relation is Part of |
NANOS Annual Meeting 2019 |
Collection |
Neuro-Ophthalmology Virtual Education Library: Walsh Session Annual Meeting Archives: https://novel.utah.edu/Walsh/ |
Publisher |
North American Neuro-Ophthalmology Society |
Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
Rights Management |
Copyright 2019. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
ARK |
ark:/87278/s6t19msg |
Setname |
ehsl_novel_fbw |
ID |
1431954 |
Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6t19msg |